ReposiTrak Announces Track and Trace Agreement
PTSM: Pharmaceutical Technology Sourcing and Management
ReposiTrak signs agreement to pilot track and trace system in pharma.
Park City Group’s ReposiTrak has signed an agreement with a biopharmaceutical manufacturer to pilot ReposiTrak’s Track & Trace solution. ReposiTrak will provide the manufacturer with visibility to product movement through the supply chain and guard against the entry of counterfeit drugs.
Using the company’s Track & Trace system, the biopharmaceutical manufacturer will track the end-to-end movement of items at the lot level. Trading partners will receive alerts to any unauthorized movement or location to ensure product authenticity and eliminate the entry of counterfeits. Once the efficacy of ReposiTrak’s Track & Trace system has been proven, the manufacturer plans to leverage the technology’s scalability and launch a full rollout.
Source: ReposiTrak
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment
February 18th 2025Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.
